DIN 02499614 — POLIVY 140 MG
POLIVY is a powder for solution of Polatuzumab vedotin marketed by HOFFMANN-LA ROCHE LIMITED. The full Polatuzumab vedotin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02499614
- Brand name
- POLIVY
- Active ingredient
- Polatuzumab vedotin
- Strength
- 140 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (CD79b-targeted antibody-drug conjugate)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Polatuzumab vedotin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02515431 | POLIVY | 30 MG | POWDER FOR SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |